| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/10/2001 | EP1141723A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists |
| 10/10/2001 | EP1141717A1 Diagnosis of sepsis using the lps-binding moiety of alkaline phosphatase |
| 10/10/2001 | EP1141407A2 Method of identifying a psychotropic agent using differential gene expression |
| 10/10/2001 | EP1141395A1 Single nucleotide polymorphism in a pyruvate dehydrogenase kinase isoenzyme 2 (pdk2) in humans |
| 10/10/2001 | EP1141389A2 Reagents and methods useful for detecting diseases of the breast |
| 10/10/2001 | EP1141386A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 10/10/2001 | EP1141376A1 Peptidoglycan recognition proteins |
| 10/10/2001 | EP1141367A1 Synthetic nucleic acid particle |
| 10/10/2001 | EP1141340A1 A method for introducing substances into cells, and use of said method |
| 10/10/2001 | EP1141339A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 10/10/2001 | EP1141326A2 Human akt-3 |
| 10/10/2001 | EP1141325A1 Ikk3 kinase |
| 10/10/2001 | EP1141319A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation |
| 10/10/2001 | EP1141318A2 P450 / acetaminophen gdept for cancer treatment |
| 10/10/2001 | EP1141313A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 10/10/2001 | EP1141290A2 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 10/10/2001 | EP1141280A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| 10/10/2001 | EP1141278A2 Therapeutic phosphodiesterase inhibitors |
| 10/10/2001 | EP1141268A2 $i(A. FUMIGATUS) ACETYL COENZYME-A CARBOXYLASE GENES AND POLYPEPTIDES AND USES THEREOF |
| 10/10/2001 | EP1141266A2 Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof |
| 10/10/2001 | EP1141252A2 Human desaturase gene and uses thereof |
| 10/10/2001 | EP1141251A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 10/10/2001 | EP1141245A1 Somatic cells with ablated prp gene and methods of use |
| 10/10/2001 | EP1141241A2 Astrocytes, their preparation and uses thereof |
| 10/10/2001 | EP1141124A1 Anionic-cationic polyion complexes comprising zwitterionic monomer component |
| 10/10/2001 | EP1141111A1 Gel compositions |
| 10/10/2001 | EP1141079A1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties |
| 10/10/2001 | EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 10/10/2001 | EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/10/2001 | EP1141017A2 Characterization of the soc/crac calcium channel protein family |
| 10/10/2001 | EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response |
| 10/10/2001 | EP1141002A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 10/10/2001 | EP1140999A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140994A1 Outer surface proteins, their genes, and their use |
| 10/10/2001 | EP1140988A1 Halovir, an antiviral marine natural product, and derivatives thereof |
| 10/10/2001 | EP1140983A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 10/10/2001 | EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 10/10/2001 | EP1140971A1 Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| 10/10/2001 | EP1140970A1 47 human secreted proteins |
| 10/10/2001 | EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof |
| 10/10/2001 | EP1140966A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 10/10/2001 | EP1140965A1 Protonated/acidified nucleic acids and methods of use |
| 10/10/2001 | EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof |
| 10/10/2001 | EP1140962A2 Novel derivatives from the class of oleandomycin |
| 10/10/2001 | EP1140960A1 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 10/10/2001 | EP1140959A1 Inositol-containing hexasaccharides, their synthesis and their uses |
| 10/10/2001 | EP1140958A1 Anti-(retro)viral conjugates of saccharides and acetamidino or guanidino compounds |
| 10/10/2001 | EP1140952A1 Organo-phosphorus compounds and their utilization |
| 10/10/2001 | EP1140948A1 Camptothecin analogs and methods of preparation thereof |
| 10/10/2001 | EP1140946A2 Quinoline derivatives |
| 10/10/2001 | EP1140945A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 10/10/2001 | EP1140944A1 Epothilone derivatives and their use as antitumor agents |
| 10/10/2001 | EP1140943A2 Substituted pyrroloindoles |
| 10/10/2001 | EP1140942A2 Prenyl transferase inhibitors |
| 10/10/2001 | EP1140941A1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 10/10/2001 | EP1140940A1 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)qinoxalin-5(6h)one derivates being 5ht2c agonists |
| 10/10/2001 | EP1140939A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods |
| 10/10/2001 | EP1140938A2 High affinity inhibitors for target validation and uses thereof |
| 10/10/2001 | EP1140937A2 Antiviral nucleoside analogues |
| 10/10/2001 | EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 10/10/2001 | EP1140935A2 1,2-annelated quinoline derivatives |
| 10/10/2001 | EP1140934A1 BENZISOXAZOLES AND PHENONES AS $g(a) 2?-ANTAGONISTS |
| 10/10/2001 | EP1140933A2 Process for preparing n6-substituted deaza-adenosine derivatives |
| 10/10/2001 | EP1140932A1 1,8-benzonaphthyridine derivatives |
| 10/10/2001 | EP1140931A1 5ht1 antagonists for antidepressant therapy |
| 10/10/2001 | EP1140930A1 DIBENZO a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF |
| 10/10/2001 | EP1140927A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists |
| 10/10/2001 | EP1140925A1 (3,4 dihydro-2h-benzo[1,4] oxazinyl-methyl)- 3-(1h-indol-3- yl)-alkyl -amines |
| 10/10/2001 | EP1140924A1 Piperazine derivatives |
| 10/10/2001 | EP1140923A1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates |
| 10/10/2001 | EP1140920A1 Piperidines as ccr5 modulators |
| 10/10/2001 | EP1140919A1 1,4-disubstituted cyclohexane derivatives for the treatment of depression |
| 10/10/2001 | EP1140918A1 Thrombin inhibitors |
| 10/10/2001 | EP1140917A1 S-oxide lipid lowering compounds |
| 10/10/2001 | EP1140916A1 Heteroaryl-cyclic acetals |
| 10/10/2001 | EP1140915A1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| 10/10/2001 | EP1140914A1 Non-peptide nk1 receptors antagonists |
| 10/10/2001 | EP1140913A1 Thiourea inhibitors of herpes viruses |
| 10/10/2001 | EP1140912A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 10/10/2001 | EP1140911A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 10/10/2001 | EP1140910A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 10/10/2001 | EP1140909A1 Novel inhibitors of farnesyl-protein transferase |
| 10/10/2001 | EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity |
| 10/10/2001 | EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity |
| 10/10/2001 | EP1140906A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| 10/10/2001 | EP1140905A1 Heteroaromatic amides as inhibitor of factor xa |
| 10/10/2001 | EP1140904A1 Farnesyl protein transferase inhibitors |
| 10/10/2001 | EP1140903A1 Aromatic amides |
| 10/10/2001 | EP1140902A1 Tricyclic farnesyl protein transferase inhibitors |
| 10/10/2001 | EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
| 10/10/2001 | EP1140900A2 Pyrazole compounds and uses thereof |
| 10/10/2001 | EP1140898A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 10/10/2001 | EP1140897A1 Protease inhibitors |
| 10/10/2001 | EP1140896A1 Benzothiepin-anilide derivatives, their production and their use for antagonizing ccr-5 |
| 10/10/2001 | EP1140895A2 Thiopyran compounds as inhibitors of mmp |
| 10/10/2001 | EP1140893A1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 10/10/2001 | EP1140891A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments |
| 10/10/2001 | EP1140889A2 Compounds and methods for modulation of estrogen receptors |
| 10/10/2001 | EP1140885A1 Method for high yield extraction of paclitaxel from paclitaxel-containing material |